Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-03-26 @ 7:53 PM
Study NCT ID:
NCT00378833
Status:
COMPLETED
Last Update Posted:
2017-02-16
First Post:
2006-09-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0524A-054
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None